JW

Jonny Wray

CTO

Nucleome Therapeutics

Oxford, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Nucleome Therapeutics
Industry
biotechnology
Employees
56.0
Seniority
C suite
Total Funding
42478500.0
Latest Funding
Series A

Technologies

Amazon SES Outlook Microsoft Office 365 Google Tag Manager WordPress.org reCAPTCHA Vimeo Mobile Friendly Remote

Keywords

regulatory genome genetic mapping personalized medicine drug discovery therapeutic targets autoimmune diseases inflammatory conditions genetic variants machine learning molecular mechanisms genetics-informed drugs gene regulation 3d genome analysis functional genomics gwas cell-type specific precision medicines disease mechanisms genetic validation ntp-464 chromatin dynamics b cell activation t cell regulation anti-inflammatory effects genomic data target discovery comprehensive analysis variant functional validation dual therapy genetics technology genetic profiling pharmaceutical collaborations genetic insights remission strategies clinical prediction druggable targets network analysis molecular characteristics 3d genomic structures population genetics complex genetic diseases dark genome gene expression functional snps genetic epidemiology cellular interactions therapeutic pathways biomarker identification artificial intelligence information technology & services

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans